Phase 1, First-in-Human Study of MEDI2228, a BCMA-Targeted ADC in Patients with Relapsed/Refractory Multiple Myeloma
- Resource Type
- Journal
- Authors
- Kumar, Shaji K.; Migkou, Magdalini; Bhutani, Manisha; Spencer, Andrew; Ailawadhi, Sikander; Kalff, Anna; Walcott, Farzana; Pore, Nabendu; Gibson, Diana; Wang, Fujun; Cheng, Lily; Kagiampakis, Ioannis; Williams, Marna; Kinneer, Krista; Jiang, Yu; Zonder, Jeffrey; Larsen, Jeremy; Sirdesai, Shreerang; Yee, Andrew J.; Dimopoulos, Meletios A.
- Source
- BLOOD; NOV 5 2020, 136 5p. Supplement: 1
- Subject
- Language
- English
- ISSN
- 15280020